| Number | GOID | Name | p-value | FDR(GOSSIP) | FWER(GOSSIP) | Holm | Sidak | BH | BY | Bonferoni |
| 1 | 7165 | signal transduction | 1.22e-05 | 0.005 | 0.001 | 0.004 | 0.004 | 0.004 | 0.02 | 0.004
|
| 2 | 7186 | G-protein coupled receptor protein signaling pathway | 5.18e-05 | 0.009 | 0.004 | 0.01 | 0.01 | 0.009 | 0.05 | 0.01
|
| 3 | 5516 | calmodulin binding | 0.0001 | 0.01 | 0.009 | 0.03 | 0.03 | 0.01 | 0.08 | 0.03
|
| 4 | 7154 | cell communication | 0.0002 | 0.02 | 0.02 | 0.09 | 0.09 | 0.01 | 0.11 | 0.09
|
| 5 | 15026 | coreceptor activity | 0.0004 | 0.03 | 0.07 | 0.15 | 0.14 | 0.01 | 0.11 | 0.15
|
| 6 | 7263 | nitric oxide mediated signal transduction | 0.0004 | 0.03 | 0.07 | 0.15 | 0.14 | 0.01 | 0.11 | 0.15
|
| 7 | 15027 | coreceptor, soluble ligand activity | 0.0004 | 0.03 | 0.07 | 0.15 | 0.14 | 0.01 | 0.11 | 0.15
|
| 8 | 6882 | zinc ion homeostasis | 0.0004 | 0.03 | 0.07 | 0.15 | 0.14 | 0.01 | 0.11 | 0.15
|
| 9 | 4871 | signal transducer activity | 0.0004 | 0.03 | 0.08 | 0.16 | 0.14 | 0.01 | 0.11 | 0.16
|
| 10 | 4872 | receptor activity | 0.002 | 0.09 | 0.22 | 0.71 | 0.51 | 0.07 | 0.47 | 0.73
|
| 11 | 7166 | cell surface receptor linked signal transduction | 0.002 | 0.10 | 0.24 | 0.86 | 0.58 | 0.08 | 0.52 | 0.89
|
| 12 | 6875 | metal ion homeostasis | 0.003 | 0.13 | 0.35 | 1 | 0.68 | 0.09 | 0.59 | 1
|
| 13 | 30005 | di-, tri-valent inorganic cation homeostasis | 0.003 | 0.13 | 0.35 | 1 | 0.68 | 0.09 | 0.59 | 1
|
| 14 | 30003 | cation homeostasis | 0.004 | 0.15 | 0.44 | 1 | 0.81 | 0.12 | 0.79 | 1
|
| 15 | 6873 | cell ion homeostasis | 0.005 | 0.15 | 0.47 | 1 | 0.86 | 0.12 | 0.82 | 1
|
| 16 | 50801 | ion homeostasis | 0.005 | 0.15 | 0.47 | 1 | 0.86 | 0.12 | 0.82 | 1
|
| 17 | 19725 | cell homeostasis | 0.007 | 0.20 | 0.57 | 1 | 0.92 | 0.13 | 0.86 | 1
|
| 18 | 42592 | homeostasis | 0.009 | 0.22 | 0.64 | 1 | 0.95 | 0.13 | 0.86 | 1
|
| 19 | 46872 | metal ion binding | 0.009 | 0.22 | 0.65 | 1 | 0.96 | 0.13 | 0.86 | 1
|
| 20 | 7242 | intracellular signaling cascade | 0.01 | 0.22 | 0.67 | 1 | 0.97 | 0.13 | 0.86 | 1
|
| 21 | 6816 | calcium ion transport | 0.01 | 0.23 | 0.71 | 1 | 0.97 | 0.13 | 0.86 | 1
|
| 22 | 6486 | protein amino acid glycosylation | 0.01 | 0.26 | 0.77 | 1 | 0.99 | 0.13 | 0.86 | 1
|
| 23 | 9100 | glycoprotein metabolism | 0.01 | 0.26 | 0.83 | 1 | 0.99 | 0.13 | 0.86 | 1
|
| 24 | 46916 | transition metal ion homeostasis | 0.01 | 0.26 | 0.83 | 1 | 0.99 | 0.13 | 0.86 | 1
|
| 25 | 5262 | calcium channel activity | 0.01 | 0.26 | 0.83 | 1 | 0.99 | 0.13 | 0.86 | 1
|
| 26 | 6936 | muscle contraction | 0.01 | 0.26 | 0.83 | 1 | 0.99 | 0.13 | 0.86 | 1
|
| 27 | 9101 | glycoprotein biosynthesis | 0.01 | 0.26 | 0.83 | 1 | 0.99 | 0.13 | 0.86 | 1
|
| 28 | 16746 | transferase activity, transferring acyl groups | 0.02 | 0.27 | 0.85 | 1 | 0.99 | 0.13 | 0.86 | 1
|
| 29 | 46463 | acylglycerol biosynthesis | 0.02 | 0.51 | 0.99 | 1 | 0.99 | 0.13 | 0.86 | 1
|
| 30 | 19432 | triacylglycerol biosynthesis | 0.02 | 0.51 | 0.99 | 1 | 0.99 | 0.13 | 0.86 | 1
|
| 31 | 46460 | neutral lipid biosynthesis | 0.02 | 0.51 | 0.99 | 1 | 0.99 | 0.13 | 0.86 | 1
|
| 32 | 4112 | cyclic-nucleotide phosphodiesterase activity | 0.02 | 0.51 | 0.99 | 1 | 0.99 | 0.13 | 0.86 | 1
|
| 33 | 4114 | 3',5'-cyclic-nucleotide phosphodiesterase activity | 0.02 | 0.51 | 0.99 | 1 | 0.99 | 0.13 | 0.86 | 1
|
| 34 | 42574 | retinal metabolism | 0.02 | 0.51 | 0.99 | 1 | 0.99 | 0.13 | 0.86 | 1
|
| 35 | 4421 | hydroxymethylglutaryl-CoA synthase activity | 0.02 | 0.51 | 0.99 | 1 | 0.99 | 0.13 | 0.86 | 1
|
| 36 | 4685 | calcium/calmodulin-dependent protein kinase activity | 0.02 | 0.51 | 0.99 | 1 | 0.99 | 0.13 | 0.86 | 1
|
| 37 | 8206 | bile acid metabolism | 0.02 | 0.51 | 0.99 | 1 | 0.99 | 0.13 | 0.86 | 1
|
| 38 | 45017 | glycerolipid biosynthesis | 0.02 | 0.51 | 0.99 | 1 | 0.99 | 0.13 | 0.86 | 1
|
| 39 | 8499 | UDP-galactose beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity | 0.02 | 0.51 | 0.99 | 1 | 0.99 | 0.13 | 0.86 | 1
|
| 40 | 3828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity | 0.02 | 0.51 | 0.99 | 1 | 0.99 | 0.13 | 0.86 | 1
|
| 41 | 8095 | inositol-1,4,5-triphosphate receptor activity | 0.02 | 0.51 | 0.99 | 1 | 0.99 | 0.13 | 0.86 | 1
|
| 42 | 4952 | dopamine receptor activity | 0.02 | 0.51 | 0.99 | 1 | 0.99 | 0.13 | 0.86 | 1
|
| 43 | 1591 | dopamine D2 receptor-like receptor activity | 0.02 | 0.51 | 0.99 | 1 | 0.99 | 0.13 | 0.86 | 1
|
| 44 | 15457 | auxiliary transport protein activity | 0.02 | 0.51 | 0.99 | 1 | 0.99 | 0.13 | 0.86 | 1
|
| 45 | 46652 | thymocyte differentiation | 0.02 | 0.51 | 0.99 | 1 | 0.99 | 0.13 | 0.86 | 1
|
| 46 | 16247 | channel regulator activity | 0.02 | 0.51 | 0.99 | 1 | 0.99 | 0.13 | 0.86 | 1
|
| 47 | 5246 | calcium channel regulator activity | 0.02 | 0.51 | 0.99 | 1 | 0.99 | 0.13 | 0.86 | 1
|
| 48 | 15278 | calcium-release channel activity | 0.02 | 0.51 | 0.99 | 1 | 0.99 | 0.13 | 0.86 | 1
|
| 49 | 5220 | inositol 1,4,5-triphosphate-sensitive calcium-release channel activity | 0.02 | 0.51 | 0.99 | 1 | 0.99 | 0.13 | 0.86 | 1
|
| 50 | 16528 | sarcoplasm | 0.02 | 0.51 | 0.99 | 1 | 0.99 | 0.13 | 0.86 | 1
|
| 51 | 5954 | calcium/calmodulin-dependent protein kinase complex | 0.02 | 0.51 | 0.99 | 1 | 0.99 | 0.13 | 0.86 | 1
|
| 52 | 3780 | actin cross-linking activity | 0.02 | 0.51 | 0.99 | 1 | 0.99 | 0.13 | 0.86 | 1
|
| 53 | 16529 | sarcoplasmic reticulum | 0.02 | 0.51 | 0.99 | 1 | 0.99 | 0.13 | 0.86 | 1
|
| 54 | 1515 | opioid peptide activity | 0.02 | 0.51 | 0.99 | 1 | 0.99 | 0.13 | 0.86 | 1
|
| 55 | 5184 | neuropeptide hormone activity | 0.02 | 0.51 | 0.99 | 1 | 0.99 | 0.13 | 0.86 | 1
|
| 56 | 5261 | cation channel activity | 0.02 | 0.51 | 0.99 | 1 | 0.99 | 0.16 | 1 | 1
|
| 57 | 5216 | ion channel activity | 0.02 | 0.51 | 0.99 | 1 | 0.99 | 0.16 | 1 | 1
|
| 58 | 15674 | di-, tri-valent inorganic cation transport | 0.02 | 0.51 | 0.99 | 1 | 0.99 | 0.16 | 1 | 1
|
| 59 | 5509 | calcium ion binding | 0.03 | 0.51 | 0.99 | 1 | 0.99 | 0.16 | 1 | 1
|
| 60 | 9987 | cellular process | 0.03 | 0.51 | 0.99 | 1 | 0.99 | 0.16 | 1 | 1
|
| 61 | 46914 | transition metal ion binding | 0.03 | 0.51 | 0.99 | 1 | 0.99 | 0.16 | 1 | 1
|
| 62 | 8270 | zinc ion binding | 0.03 | 0.51 | 0.99 | 1 | 1 | 0.16 | 1 | 1
|
| 63 | 15268 | alpha-type channel activity | 0.03 | 0.51 | 0.99 | 1 | 1 | 0.16 | 1 | 1
|
| 64 | 15267 | channel/pore class transporter activity | 0.03 | 0.51 | 0.99 | 1 | 1 | 0.16 | 1 | 1
|
| 65 | 8150 | biological_process | 0.03 | 0.51 | 0.99 | 1 | 1 | 0.16 | 1 | 1
|
| 66 | 16411 | acylglycerol O-acyltransferase activity | 0.04 | 0.61 | 0.99 | 1 | 1 | 0.16 | 1 | 1
|
| 67 | 4144 | diacylglycerol O-acyltransferase activity | 0.04 | 0.61 | 0.99 | 1 | 1 | 0.16 | 1 | 1
|
| 68 | 4864 | protein phosphatase inhibitor activity | 0.04 | 0.61 | 0.99 | 1 | 1 | 0.16 | 1 | 1
|
| 69 | 7190 | adenylate cyclase activation | 0.04 | 0.61 | 0.99 | 1 | 1 | 0.16 | 1 | 1
|
| 70 | 6904 | vesicle docking during the process of exocytosis | 0.04 | 0.61 | 0.99 | 1 | 1 | 0.16 | 1 | 1
|
| 71 | 19212 | phosphatase inhibitor activity | 0.04 | 0.61 | 0.99 | 1 | 1 | 0.16 | 1 | 1
|
| 72 | 48278 | vesicle docking | 0.04 | 0.61 | 0.99 | 1 | 1 | 0.16 | 1 | 1
|
| 73 | 7189 | G-protein signaling, adenylate cyclase activating pathway | 0.04 | 0.61 | 0.99 | 1 | 1 | 0.16 | 1 | 1
|
| 74 | 6937 | regulation of muscle contraction | 0.04 | 0.61 | 0.99 | 1 | 1 | 0.16 | 1 | 1
|
| 75 | 7548 | sex differentiation | 0.04 | 0.61 | 0.99 | 1 | 1 | 0.16 | 1 | 1
|
| 76 | 9190 | cyclic nucleotide biosynthesis | 0.04 | 0.61 | 0.99 | 1 | 1 | 0.16 | 1 | 1
|
| 77 | 6171 | cAMP biosynthesis | 0.04 | 0.61 | 0.99 | 1 | 1 | 0.16 | 1 | 1
|
| 78 | 9187 | cyclic nucleotide metabolism | 0.04 | 0.61 | 0.99 | 1 | 1 | 0.16 | 1 | 1
|
| 79 | 46058 | cAMP metabolism | 0.04 | 0.61 | 0.99 | 1 | 1 | 0.16 | 1 | 1
|
| 80 | 4016 | adenylate cyclase activity | 0.04 | 0.61 | 0.99 | 1 | 1 | 0.16 | 1 | 1
|
| 81 | 6775 | fat-soluble vitamin metabolism | 0.04 | 0.61 | 0.99 | 1 | 1 | 0.16 | 1 | 1
|
| 82 | 16849 | phosphorus-oxygen lyase activity | 0.04 | 0.61 | 0.99 | 1 | 1 | 0.16 | 1 | 1
|
| 83 | 4683 | calmodulin regulated protein kinase activity | 0.04 | 0.61 | 0.99 | 1 | 1 | 0.16 | 1 | 1
|
| 84 | 6776 | vitamin A metabolism | 0.04 | 0.61 | 0.99 | 1 | 1 | 0.16 | 1 | 1
|
| 85 | 8188 | neuropeptide receptor activity | 0.04 | 0.61 | 0.99 | 1 | 1 | 0.16 | 1 | 1
|
| 86 | 4983 | neuropeptide Y receptor activity | 0.04 | 0.61 | 0.99 | 1 | 1 | 0.16 | 1 | 1
|
| 87 | 42923 | neuropeptide binding | 0.04 | 0.61 | 0.99 | 1 | 1 | 0.16 | 1 | 1
|
| 88 | 6955 | immune response | 0.05 | 0.63 | 0.99 | 1 | 1 | 0.19 | 1 | 1
|
| 89 | 9605 | response to external stimulus | 0.05 | 0.63 | 0.99 | 1 | 1 | 0.19 | 1 | 1
|
| 90 | 30695 | GTPase regulator activity | 0.05 | 0.63 | 0.99 | 1 | 1 | 0.19 | 1 | 1
|
| 91 | 6811 | ion transport | 0.05 | 0.63 | 1 | 1 | 1 | 0.19 | 1 | 1
|
| 92 | 4935 | adrenoceptor activity | 0.06 | 0.63 | 1 | 1 | 1 | 0.19 | 1 | 1
|
| 93 | 8374 | O-acyltransferase activity | 0.06 | 0.63 | 1 | 1 | 1 | 0.19 | 1 | 1
|
| 94 | 16764 | transferase activity, transferring other glycosyl groups | 0.06 | 0.63 | 1 | 1 | 1 | 0.19 | 1 | 1
|
| 95 | 42379 | chemokine receptor binding | 0.06 | 0.63 | 1 | 1 | 1 | 0.19 | 1 | 1
|
| 96 | 42493 | response to drug | 0.06 | 0.63 | 1 | 1 | 1 | 0.19 | 1 | 1
|
| 97 | 8009 | chemokine activity | 0.06 | 0.63 | 1 | 1 | 1 | 0.19 | 1 | 1
|
| 98 | 42446 | hormone biosynthesis | 0.06 | 0.63 | 1 | 1 | 1 | 0.19 | 1 | 1
|
| 99 | 19233 | perception of pain | 0.06 | 0.63 | 1 | 1 | 1 | 0.19 | 1 | 1
|
| 100 | 6700 | C21-steroid hormone biosynthesis | 0.06 | 0.63 | 1 | 1 | 1 | 0.19 | 1 | 1
|
| 101 | 7033 | vacuole organization and biogenesis | 0.06 | 0.63 | 1 | 1 | 1 | 0.19 | 1 | 1
|
| 102 | 8373 | sialyltransferase activity | 0.06 | 0.63 | 1 | 1 | 1 | 0.19 | 1 | 1
|
| 103 | 7405 | neuroblast proliferation | 0.06 | 0.63 | 1 | 1 | 1 | 0.19 | 1 | 1
|
| 104 | 42056 | chemoattractant activity | 0.06 | 0.63 | 1 | 1 | 1 | 0.19 | 1 | 1
|
| 105 | 6944 | membrane fusion | 0.06 | 0.63 | 1 | 1 | 1 | 0.19 | 1 | 1
|
| 106 | 46912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer | 0.06 | 0.63 | 1 | 1 | 1 | 0.19 | 1 | 1
|
| 107 | 42596 | fear response | 0.06 | 0.63 | 1 | 1 | 1 | 0.19 | 1 | 1
|
| 108 | 5865 | striated muscle thin filament | 0.06 | 0.63 | 1 | 1 | 1 | 0.19 | 1 | 1
|
| 109 | 4111 | creatine kinase activity | 0.06 | 0.63 | 1 | 1 | 1 | 0.19 | 1 | 1
|
| 110 | 8207 | C21-steroid hormone metabolism | 0.06 | 0.63 | 1 | 1 | 1 | 0.19 | 1 | 1
|
| 111 | 1662 | behavioral fear response | 0.06 | 0.63 | 1 | 1 | 1 | 0.19 | 1 | 1
|
| 112 | 6812 | cation transport | 0.06 | 0.63 | 1 | 1 | 1 | 0.19 | 1 | 1
|
| 113 | 8202 | steroid metabolism | 0.06 | 0.63 | 1 | 1 | 1 | 0.20 | 1 | 1
|
| 114 | 15276 | ligand-gated ion channel activity | 0.06 | 0.63 | 1 | 1 | 1 | 0.20 | 1 | 1
|
| 115 | 30001 | metal ion transport | 0.06 | 0.63 | 1 | 1 | 1 | 0.20 | 1 | 1
|
| 116 | 5096 | GTPase activator activity | 0.07 | 0.63 | 1 | 1 | 1 | 0.21 | 1 | 1
|
| 117 | 5871 | kinesin complex | 0.08 | 0.63 | 1 | 1 | 1 | 0.22 | 1 | 1
|
| 118 | 7188 | G-protein signaling, coupled to cAMP nucleotide second messenger | 0.08 | 0.63 | 1 | 1 | 1 | 0.22 | 1 | 1
|
| 119 | 4029 | aldehyde dehydrogenase (NAD) activity | 0.08 | 0.63 | 1 | 1 | 1 | 0.22 | 1 | 1
|
| 120 | 30098 | lymphocyte differentiation | 0.08 | 0.63 | 1 | 1 | 1 | 0.22 | 1 | 1
|
| 121 | 5217 | intracellular ligand-gated ion channel activity | 0.08 | 0.63 | 1 | 1 | 1 | 0.22 | 1 | 1
|
| 122 | 7187 | G-protein signaling, coupled to cyclic nucleotide second messenger | 0.08 | 0.63 | 1 | 1 | 1 | 0.22 | 1 | 1
|
| 123 | 30484 | muscle fiber | 0.08 | 0.63 | 1 | 1 | 1 | 0.22 | 1 | 1
|
| 124 | 5507 | copper ion binding | 0.08 | 0.63 | 1 | 1 | 1 | 0.22 | 1 | 1
|
| 125 | 4028 | aldehyde dehydrogenase activity | 0.08 | 0.63 | 1 | 1 | 1 | 0.22 | 1 | 1
|
| 126 | 30016 | myofibril | 0.08 | 0.63 | 1 | 1 | 1 | 0.22 | 1 | 1
|
| 127 | 30017 | sarcomere | 0.08 | 0.63 | 1 | 1 | 1 | 0.22 | 1 | 1
|
| 128 | 1664 | G-protein-coupled receptor binding | 0.08 | 0.63 | 1 | 1 | 1 | 0.22 | 1 | 1
|
| 129 | 42578 | phosphoric ester hydrolase activity | 0.08 | 0.63 | 1 | 1 | 1 | 0.22 | 1 | 1
|
| 130 | 8415 | acyltransferase activity | 0.08 | 0.63 | 1 | 1 | 1 | 0.22 | 1 | 1
|
| 131 | 5941 | unlocalized | 0.09 | 0.63 | 1 | 1 | 1 | 0.22 | 1 | 1
|
| 132 | 16747 | transferase activity, transferring groups other than amino-acyl groups | 0.09 | 0.63 | 1 | 1 | 1 | 0.22 | 1 | 1
|
| 133 | 6952 | defense response | 0.09 | 0.63 | 1 | 1 | 1 | 0.22 | 1 | 1
|
| 134 | 8227 | amine receptor activity | 0.10 | 0.63 | 1 | 1 | 1 | 0.22 | 1 | 1
|
| 135 | 3707 | steroid hormone receptor activity | 0.10 | 0.63 | 1 | 1 | 1 | 0.22 | 1 | 1
|
| 136 | 163 | protein phosphatase type 1 activity | 0.10 | 0.63 | 1 | 1 | 1 | 0.22 | 1 | 1
|
| 137 | 17018 | myosin phosphatase activity | 0.10 | 0.63 | 1 | 1 | 1 | 0.22 | 1 | 1
|
| 138 | 158 | protein phosphatase type 2A activity | 0.10 | 0.63 | 1 | 1 | 1 | 0.22 | 1 | 1
|
| 139 | 30117 | membrane coat | 0.10 | 0.63 | 1 | 1 | 1 | 0.22 | 1 | 1
|
| 140 | 15071 | protein phosphatase type 2C activity | 0.10 | 0.63 | 1 | 1 | 1 | 0.22 | 1 | 1
|
| 141 | 30118 | clathrin coat | 0.10 | 0.63 | 1 | 1 | 1 | 0.22 | 1 | 1
|
| 142 | 6874 | calcium ion homeostasis | 0.10 | 0.63 | 1 | 1 | 1 | 0.22 | 1 | 1
|
| 143 | 8528 | peptide receptor activity, G-protein coupled | 0.10 | 0.63 | 1 | 1 | 1 | 0.22 | 1 | 1
|
| 144 | 1653 | peptide receptor activity | 0.10 | 0.63 | 1 | 1 | 1 | 0.22 | 1 | 1
|
| 145 | 16775 | phosphotransferase activity, nitrogenous group as acceptor | 0.10 | 0.63 | 1 | 1 | 1 | 0.22 | 1 | 1
|
| 146 | 3930 | RAS small monomeric GTPase activity | 0.10 | 0.63 | 1 | 1 | 1 | 0.22 | 1 | 1
|
| 147 | 6084 | acetyl-CoA metabolism | 0.10 | 0.63 | 1 | 1 | 1 | 0.22 | 1 | 1
|
| 148 | 30120 | vesicle coat | 0.10 | 0.63 | 1 | 1 | 1 | 0.22 | 1 | 1
|
| 149 | 30125 | clathrin vesicle coat | 0.10 | 0.63 | 1 | 1 | 1 | 0.22 | 1 | 1
|
| 150 | 6662 | glycerol ether metabolism | 0.10 | 0.63 | 1 | 1 | 1 | 0.22 | 1 | 1
|
| 151 | 6639 | acylglycerol metabolism | 0.10 | 0.63 | 1 | 1 | 1 | 0.22 | 1 | 1
|
| 152 | 6641 | triacylglycerol metabolism | 0.10 | 0.63 | 1 | 1 | 1 | 0.22 | 1 | 1
|
| 153 | 8378 | galactosyltransferase activity | 0.10 | 0.63 | 1 | 1 | 1 | 0.22 | 1 | 1
|
| 154 | 46486 | glycerolipid metabolism | 0.10 | 0.63 | 1 | 1 | 1 | 0.22 | 1 | 1
|
| 155 | 6695 | cholesterol biosynthesis | 0.10 | 0.63 | 1 | 1 | 1 | 0.22 | 1 | 1
|
| 156 | 16126 | sterol biosynthesis | 0.10 | 0.63 | 1 | 1 | 1 | 0.22 | 1 | 1
|
| 157 | 6638 | neutral lipid metabolism | 0.10 | 0.63 | 1 | 1 | 1 | 0.22 | 1 | 1
|
| 158 | 30234 | enzyme regulator activity | 0.11 | 0.64 | 1 | 1 | 1 | 0.24 | 1 | 1
|
| 159 | 5875 | microtubule associated complex | 0.11 | 0.64 | 1 | 1 | 1 | 0.24 | 1 | 1
|
| 160 | 16311 | dephosphorylation | 0.11 | 0.64 | 1 | 1 | 1 | 0.24 | 1 | 1
|
| 161 | 46649 | lymphocyte activation | 0.12 | 0.65 | 1 | 1 | 1 | 0.24 | 1 | 1
|
| 162 | 45321 | immune cell activation | 0.12 | 0.65 | 1 | 1 | 1 | 0.24 | 1 | 1
|
| 163 | 1775 | cell activation | 0.12 | 0.65 | 1 | 1 | 1 | 0.24 | 1 | 1
|
| 164 | 6073 | glucan metabolism | 0.12 | 0.65 | 1 | 1 | 1 | 0.24 | 1 | 1
|
| 165 | 5977 | glycogen metabolism | 0.12 | 0.65 | 1 | 1 | 1 | 0.24 | 1 | 1
|
| 166 | 4879 | ligand-dependent nuclear receptor activity | 0.12 | 0.65 | 1 | 1 | 1 | 0.24 | 1 | 1
|
| 167 | 8420 | CTD phosphatase activity | 0.12 | 0.65 | 1 | 1 | 1 | 0.24 | 1 | 1
|
| 168 | 6112 | energy reserve metabolism | 0.12 | 0.65 | 1 | 1 | 1 | 0.24 | 1 | 1
|
| 169 | 19933 | cAMP-mediated signaling | 0.12 | 0.65 | 1 | 1 | 1 | 0.24 | 1 | 1
|
| 170 | 19935 | cyclic-nucleotide-mediated signaling | 0.12 | 0.65 | 1 | 1 | 1 | 0.24 | 1 | 1
|
| 171 | 8047 | enzyme activator activity | 0.12 | 0.65 | 1 | 1 | 1 | 0.25 | 1 | 1
|
| 172 | 16757 | transferase activity, transferring glycosyl groups | 0.13 | 0.66 | 1 | 1 | 1 | 0.26 | 1 | 1
|
| 173 | 8610 | lipid biosynthesis | 0.13 | 0.66 | 1 | 1 | 1 | 0.26 | 1 | 1
|
| 174 | 7265 | RAS protein signal transduction | 0.13 | 0.67 | 1 | 1 | 1 | 0.26 | 1 | 1
|
| 175 | 19932 | second-messenger-mediated signaling | 0.13 | 0.67 | 1 | 1 | 1 | 0.26 | 1 | 1
|
| 176 | 6766 | vitamin metabolism | 0.13 | 0.67 | 1 | 1 | 1 | 0.26 | 1 | 1
|
| 177 | 19888 | protein phosphatase regulator activity | 0.13 | 0.67 | 1 | 1 | 1 | 0.26 | 1 | 1
|
| 178 | 19208 | phosphatase regulator activity | 0.13 | 0.67 | 1 | 1 | 1 | 0.26 | 1 | 1
|
| 179 | 30097 | hemopoiesis | 0.13 | 0.67 | 1 | 1 | 1 | 0.26 | 1 | 1
|
| 180 | 42445 | hormone metabolism | 0.13 | 0.67 | 1 | 1 | 1 | 0.26 | 1 | 1
|
| 181 | 5976 | polysaccharide metabolism | 0.13 | 0.67 | 1 | 1 | 1 | 0.26 | 1 | 1
|
| 182 | 6810 | transport | 0.13 | 0.67 | 1 | 1 | 1 | 0.26 | 1 | 1
|
| 183 | 5856 | cytoskeleton | 0.14 | 0.67 | 1 | 1 | 1 | 0.27 | 1 | 1
|
| 184 | 4721 | phosphoprotein phosphatase activity | 0.14 | 0.67 | 1 | 1 | 1 | 0.27 | 1 | 1
|
| 185 | 7268 | synaptic transmission | 0.14 | 0.67 | 1 | 1 | 1 | 0.27 | 1 | 1
|
| 186 | 19226 | transmission of nerve impulse | 0.15 | 0.67 | 1 | 1 | 1 | 0.28 | 1 | 1
|
| 187 | 6694 | steroid biosynthesis | 0.15 | 0.69 | 1 | 1 | 1 | 0.29 | 1 | 1
|
| 188 | 16410 | N-acyltransferase activity | 0.15 | 0.69 | 1 | 1 | 1 | 0.29 | 1 | 1
|
| 189 | 7218 | neuropeptide signaling pathway | 0.15 | 0.69 | 1 | 1 | 1 | 0.29 | 1 | 1
|
| 190 | 16620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor | 0.15 | 0.69 | 1 | 1 | 1 | 0.29 | 1 | 1
|
| 191 | 6928 | cell motility | 0.16 | 0.69 | 1 | 1 | 1 | 0.29 | 1 | 1
|
| 192 | 9607 | response to biotic stimulus | 0.16 | 0.69 | 1 | 1 | 1 | 0.29 | 1 | 1
|
| 193 | 7267 | cell-cell signaling | 0.16 | 0.69 | 1 | 1 | 1 | 0.30 | 1 | 1
|
| 194 | 6464 | protein modification | 0.17 | 0.69 | 1 | 1 | 1 | 0.30 | 1 | 1
|
| 195 | 16903 | oxidoreductase activity, acting on the aldehyde or oxo group of donors | 0.17 | 0.70 | 1 | 1 | 1 | 0.30 | 1 | 1
|
| 196 | 8081 | phosphoric diester hydrolase activity | 0.17 | 0.70 | 1 | 1 | 1 | 0.30 | 1 | 1
|
| 197 | 5179 | hormone activity | 0.17 | 0.70 | 1 | 1 | 1 | 0.30 | 1 | 1
|
| 198 | 16917 | GABA receptor activity | 0.17 | 0.70 | 1 | 1 | 1 | 0.30 | 1 | 1
|
| 199 | 7214 | gamma-aminobutyric acid signaling pathway | 0.17 | 0.70 | 1 | 1 | 1 | 0.30 | 1 | 1
|
| 200 | 4890 | GABA-A receptor activity | 0.17 | 0.70 | 1 | 1 | 1 | 0.30 | 1 | 1
|
| 201 | 6836 | neurotransmitter transport | 0.17 | 0.70 | 1 | 1 | 1 | 0.30 | 1 | 1
|
| 202 | 5085 | guanyl-nucleotide exchange factor activity | 0.17 | 0.70 | 1 | 1 | 1 | 0.30 | 1 | 1
|
| 203 | 7266 | Rho protein signal transduction | 0.17 | 0.70 | 1 | 1 | 1 | 0.30 | 1 | 1
|
| 204 | 16829 | lyase activity | 0.18 | 0.70 | 1 | 1 | 1 | 0.31 | 1 | 1
|
| 205 | 15630 | microtubule cytoskeleton | 0.18 | 0.70 | 1 | 1 | 1 | 0.31 | 1 | 1
|
| 206 | 6887 | exocytosis | 0.19 | 0.73 | 1 | 1 | 1 | 0.32 | 1 | 1
|
| 207 | 42277 | peptide binding | 0.19 | 0.73 | 1 | 1 | 1 | 0.32 | 1 | 1
|
| 208 | 5802 | Golgi trans face | 0.19 | 0.73 | 1 | 1 | 1 | 0.32 | 1 | 1
|
| 209 | 5102 | receptor binding | 0.19 | 0.73 | 1 | 1 | 1 | 0.33 | 1 | 1
|
| 210 | 3779 | actin binding | 0.19 | 0.73 | 1 | 1 | 1 | 0.33 | 1 | 1
|
| 211 | 4722 | protein serine/threonine phosphatase activity | 0.20 | 0.75 | 1 | 1 | 1 | 0.34 | 1 | 1
|
| 212 | 8287 | protein serine/threonine phosphatase complex | 0.20 | 0.75 | 1 | 1 | 1 | 0.34 | 1 | 1
|
| 213 | 15629 | actin cytoskeleton | 0.22 | 0.75 | 1 | 1 | 1 | 0.36 | 1 | 1
|
| 214 | 16740 | transferase activity | 0.22 | 0.75 | 1 | 1 | 1 | 0.36 | 1 | 1
|
| 215 | 30594 | neurotransmitter receptor activity | 0.22 | 0.75 | 1 | 1 | 1 | 0.36 | 1 | 1
|
| 216 | 7600 | sensory perception | 0.22 | 0.75 | 1 | 1 | 1 | 0.36 | 1 | 1
|
| 217 | 5125 | cytokine activity | 0.22 | 0.75 | 1 | 1 | 1 | 0.36 | 1 | 1
|
| 218 | 42165 | neurotransmitter binding | 0.22 | 0.75 | 1 | 1 | 1 | 0.36 | 1 | 1
|
| 219 | 16192 | vesicle-mediated transport | 0.23 | 0.75 | 1 | 1 | 1 | 0.36 | 1 | 1
|
| 220 | 16791 | phosphoric monoester hydrolase activity | 0.23 | 0.75 | 1 | 1 | 1 | 0.36 | 1 | 1
|
| 221 | 7582 | physiological process | 0.23 | 0.75 | 1 | 1 | 1 | 0.37 | 1 | 1
|
| 222 | 5794 | Golgi apparatus | 0.23 | 0.75 | 1 | 1 | 1 | 0.37 | 1 | 1
|
| 223 | 16788 | hydrolase activity, acting on ester bonds | 0.23 | 0.75 | 1 | 1 | 1 | 0.37 | 1 | 1
|
| 224 | 16021 | integral to membrane | 0.24 | 0.75 | 1 | 1 | 1 | 0.37 | 1 | 1
|
| 225 | 8203 | cholesterol metabolism | 0.24 | 0.76 | 1 | 1 | 1 | 0.37 | 1 | 1
|
| 226 | 16125 | sterol metabolism | 0.24 | 0.76 | 1 | 1 | 1 | 0.37 | 1 | 1
|
| 227 | 42221 | response to chemical substance | 0.24 | 0.76 | 1 | 1 | 1 | 0.37 | 1 | 1
|
| 228 | 9581 | perception of external stimulus | 0.25 | 0.77 | 1 | 1 | 1 | 0.39 | 1 | 1
|
| 229 | 6821 | chloride transport | 0.25 | 0.77 | 1 | 1 | 1 | 0.39 | 1 | 1
|
| 230 | 5249 | voltage-gated potassium channel activity | 0.25 | 0.77 | 1 | 1 | 1 | 0.39 | 1 | 1
|
| 231 | 5515 | protein binding | 0.25 | 0.77 | 1 | 1 | 1 | 0.39 | 1 | 1
|
| 232 | 8151 | cell growth and/or maintenance | 0.26 | 0.77 | 1 | 1 | 1 | 0.40 | 1 | 1
|
| 233 | 30145 | manganese ion binding | 0.27 | 0.80 | 1 | 1 | 1 | 0.41 | 1 | 1
|
| 234 | 5905 | coated pit | 0.27 | 0.80 | 1 | 1 | 1 | 0.41 | 1 | 1
|
| 235 | 6629 | lipid metabolism | 0.27 | 0.80 | 1 | 1 | 1 | 0.41 | 1 | 1
|
| 236 | 16020 | membrane | 0.28 | 0.80 | 1 | 1 | 1 | 0.41 | 1 | 1
|
| 237 | 5230 | extracellular ligand-gated ion channel activity | 0.29 | 0.81 | 1 | 1 | 1 | 0.42 | 1 | 1
|
| 238 | 5057 | receptor signaling protein activity | 0.29 | 0.81 | 1 | 1 | 1 | 0.42 | 1 | 1
|
| 239 | 1584 | rhodopsin-like receptor activity | 0.30 | 0.83 | 1 | 1 | 1 | 0.44 | 1 | 1
|
| 240 | 16758 | transferase activity, transferring hexosyl groups | 0.30 | 0.83 | 1 | 1 | 1 | 0.44 | 1 | 1
|
| 241 | 7243 | protein kinase cascade | 0.30 | 0.83 | 1 | 1 | 1 | 0.44 | 1 | 1
|
| 242 | 15698 | inorganic anion transport | 0.30 | 0.83 | 1 | 1 | 1 | 0.44 | 1 | 1
|
| 243 | 6793 | phosphorus metabolism | 0.31 | 0.83 | 1 | 1 | 1 | 0.45 | 1 | 1
|
| 244 | 6796 | phosphate metabolism | 0.31 | 0.83 | 1 | 1 | 1 | 0.45 | 1 | 1
|
| 245 | 45045 | secretory pathway | 0.32 | 0.84 | 1 | 1 | 1 | 0.45 | 1 | 1
|
| 246 | 8092 | cytoskeletal protein binding | 0.32 | 0.84 | 1 | 1 | 1 | 0.46 | 1 | 1
|
| 247 | 4725 | protein-tyrosine-phosphatase activity | 0.33 | 0.85 | 1 | 1 | 1 | 0.47 | 1 | 1
|
| 248 | 5267 | potassium channel activity | 0.34 | 0.88 | 1 | 1 | 1 | 0.49 | 1 | 1
|
| 249 | 30136 | clathrin-coated vesicle | 0.36 | 0.89 | 1 | 1 | 1 | 0.50 | 1 | 1
|
| 250 | 910 | cytokinesis | 0.36 | 0.89 | 1 | 1 | 1 | 0.50 | 1 | 1
|
| 251 | 3700 | transcription factor activity | 0.36 | 0.89 | 1 | 1 | 1 | 0.51 | 1 | 1
|
| 252 | 4930 | G-protein coupled receptor activity | 0.37 | 0.90 | 1 | 1 | 1 | 0.52 | 1 | 1
|
| 253 | 7264 | small GTPase mediated signal transduction | 0.37 | 0.90 | 1 | 1 | 1 | 0.52 | 1 | 1
|
| 254 | 30135 | coated vesicle | 0.38 | 0.91 | 1 | 1 | 1 | 0.53 | 1 | 1
|
| 255 | 5244 | voltage-gated ion channel activity | 0.40 | 0.92 | 1 | 1 | 1 | 0.55 | 1 | 1
|
| 256 | 6813 | potassium ion transport | 0.41 | 0.93 | 1 | 1 | 1 | 0.56 | 1 | 1
|
| 257 | 6820 | anion transport | 0.41 | 0.93 | 1 | 1 | 1 | 0.56 | 1 | 1
|
| 258 | 4888 | transmembrane receptor activity | 0.41 | 0.93 | 1 | 1 | 1 | 0.56 | 1 | 1
|
| 259 | 16301 | kinase activity | 0.42 | 0.93 | 1 | 1 | 1 | 0.57 | 1 | 1
|
| 260 | 5783 | endoplasmic reticulum | 0.42 | 0.93 | 1 | 1 | 1 | 0.57 | 1 | 1
|
| 261 | 7610 | behavior | 0.42 | 0.93 | 1 | 1 | 1 | 0.57 | 1 | 1
|
| 262 | 4857 | enzyme inhibitor activity | 0.42 | 0.93 | 1 | 1 | 1 | 0.57 | 1 | 1
|
| 263 | 5215 | transporter activity | 0.42 | 0.93 | 1 | 1 | 1 | 0.57 | 1 | 1
|
| 264 | 9059 | macromolecule biosynthesis | 0.43 | 0.93 | 1 | 1 | 1 | 0.57 | 1 | 1
|
| 265 | 6470 | protein amino acid dephosphorylation | 0.44 | 0.93 | 1 | 1 | 1 | 0.58 | 1 | 1
|
| 266 | 15891 | siderochrome transport | 0.45 | 0.95 | 1 | 1 | 1 | 0.59 | 1 | 1
|
| 267 | 5886 | plasma membrane | 0.47 | 0.96 | 1 | 1 | 1 | 0.61 | 1 | 1
|
| 268 | 5764 | lysosome | 0.47 | 0.96 | 1 | 1 | 1 | 0.61 | 1 | 1
|
| 269 | 323 | lytic vacuole | 0.47 | 0.96 | 1 | 1 | 1 | 0.61 | 1 | 1
|
| 270 | 5083 | small GTPase regulatory/interacting protein activity | 0.47 | 0.96 | 1 | 1 | 1 | 0.61 | 1 | 1
|
| 271 | 9628 | response to abiotic stimulus | 0.48 | 0.96 | 1 | 1 | 1 | 0.63 | 1 | 1
|
| 272 | 9165 | nucleotide biosynthesis | 0.50 | 0.98 | 1 | 1 | 1 | 0.65 | 1 | 1
|
| 273 | 5773 | vacuole | 0.51 | 0.99 | 1 | 1 | 1 | 0.66 | 1 | 1
|
| 274 | 6732 | coenzyme metabolism | 0.51 | 0.99 | 1 | 1 | 1 | 0.66 | 1 | 1
|
| 275 | 4713 | protein-tyrosine kinase activity | 0.52 | 0.99 | 1 | 1 | 1 | 0.66 | 1 | 1
|
| 276 | 5887 | integral to plasma membrane | 0.52 | 0.99 | 1 | 1 | 1 | 0.66 | 1 | 1
|
| 277 | 7049 | cell cycle | 0.54 | 0.99 | 1 | 1 | 1 | 0.68 | 1 | 1
|
| 278 | 16023 | cytoplasmic vesicle | 0.54 | 0.99 | 1 | 1 | 1 | 0.69 | 1 | 1
|
| 279 | 30528 | transcription regulator activity | 0.56 | 0.99 | 1 | 1 | 1 | 0.71 | 1 | 1
|
| 280 | 5576 | extracellular | 0.57 | 0.99 | 1 | 1 | 1 | 0.72 | 1 | 1
|
| 281 | 30154 | cell differentiation | 0.57 | 0.99 | 1 | 1 | 1 | 0.72 | 1 | 1
|
| 282 | 9117 | nucleotide metabolism | 0.58 | 0.99 | 1 | 1 | 1 | 0.73 | 1 | 1
|
| 283 | 6091 | energy pathways | 0.59 | 0.99 | 1 | 1 | 1 | 0.73 | 1 | 1
|
| 284 | 15980 | energy derivation by oxidation of organic compounds | 0.59 | 0.99 | 1 | 1 | 1 | 0.73 | 1 | 1
|
| 285 | 9058 | biosynthesis | 0.59 | 0.99 | 1 | 1 | 1 | 0.73 | 1 | 1
|
| 286 | 5525 | GTP binding | 0.59 | 0.99 | 1 | 1 | 1 | 0.73 | 1 | 1
|
| 287 | 19001 | guanyl nucleotide binding | 0.59 | 0.99 | 1 | 1 | 1 | 0.73 | 1 | 1
|
| 288 | 6731 | coenzyme and prosthetic group metabolism | 0.60 | 0.99 | 1 | 1 | 1 | 0.73 | 1 | 1
|
| 289 | 3925 | small monomeric GTPase activity | 0.62 | 0.99 | 1 | 1 | 1 | 0.75 | 1 | 1
|
| 290 | 4674 | protein serine/threonine kinase activity | 0.62 | 0.99 | 1 | 1 | 1 | 0.75 | 1 | 1
|
| 291 | 6468 | protein amino acid phosphorylation | 0.62 | 0.99 | 1 | 1 | 1 | 0.75 | 1 | 1
|
| 292 | 6066 | alcohol metabolism | 0.63 | 0.99 | 1 | 1 | 1 | 0.76 | 1 | 1
|
| 293 | 5194 | cell adhesion molecule activity | 0.64 | 0.99 | 1 | 1 | 1 | 0.77 | 1 | 1
|
| 294 | 5667 | transcription factor complex | 0.65 | 0.99 | 1 | 1 | 1 | 0.77 | 1 | 1
|
| 295 | 5615 | extracellular space | 0.66 | 0.99 | 1 | 1 | 1 | 0.78 | 1 | 1
|
| 296 | 16310 | phosphorylation | 0.66 | 0.99 | 1 | 1 | 1 | 0.78 | 1 | 1
|
| 297 | 5489 | electron transporter activity | 0.66 | 0.99 | 1 | 1 | 1 | 0.78 | 1 | 1
|
| 298 | 7399 | neurogenesis | 0.66 | 0.99 | 1 | 1 | 1 | 0.78 | 1 | 1
|
| 299 | 8283 | cell proliferation | 0.67 | 0.99 | 1 | 1 | 1 | 0.79 | 1 | 1
|
| 300 | 4672 | protein kinase activity | 0.68 | 0.99 | 1 | 1 | 1 | 0.80 | 1 | 1
|
| 301 | 15672 | monovalent inorganic cation transport | 0.69 | 0.99 | 1 | 1 | 1 | 0.81 | 1 | 1
|
| 302 | 3674 | molecular_function | 0.70 | 0.99 | 1 | 1 | 1 | 0.81 | 1 | 1
|
| 303 | 9887 | organogenesis | 0.71 | 0.99 | 1 | 1 | 1 | 0.82 | 1 | 1
|
| 304 | 50800 | hydrolase activity, acting on acid anhydrides, acting on GTP, involved in cellular and subcellular movement | 0.72 | 0.99 | 1 | 1 | 1 | 0.82 | 1 | 1
|
| 305 | 16772 | transferase activity, transferring phosphorus-containing groups | 0.72 | 0.99 | 1 | 1 | 1 | 0.82 | 1 | 1
|
| 306 | 6886 | intracellular protein transport | 0.74 | 0.99 | 1 | 1 | 1 | 0.85 | 1 | 1
|
| 307 | 5488 | binding | 0.74 | 0.99 | 1 | 1 | 1 | 0.85 | 1 | 1
|
| 308 | 74 | regulation of cell cycle | 0.75 | 0.99 | 1 | 1 | 1 | 0.86 | 1 | 1
|
| 309 | 5737 | cytoplasm | 0.75 | 0.99 | 1 | 1 | 1 | 0.86 | 1 | 1
|
| 310 | 7155 | cell adhesion | 0.76 | 0.99 | 1 | 1 | 1 | 0.86 | 1 | 1
|
| 311 | 16773 | phosphotransferase activity, alcohol group as acceptor | 0.76 | 0.99 | 1 | 1 | 1 | 0.86 | 1 | 1
|
| 312 | 3924 | GTPase activity | 0.77 | 0.99 | 1 | 1 | 1 | 0.86 | 1 | 1
|
| 313 | 15031 | protein transport | 0.77 | 0.99 | 1 | 1 | 1 | 0.86 | 1 | 1
|
| 314 | 9653 | morphogenesis | 0.77 | 0.99 | 1 | 1 | 1 | 0.86 | 1 | 1
|
| 315 | 5975 | carbohydrate metabolism | 0.78 | 0.99 | 1 | 1 | 1 | 0.86 | 1 | 1
|
| 316 | 16491 | oxidoreductase activity | 0.78 | 0.99 | 1 | 1 | 1 | 0.86 | 1 | 1
|
| 317 | 6412 | protein biosynthesis | 0.78 | 0.99 | 1 | 1 | 1 | 0.87 | 1 | 1
|
| 318 | 5654 | nucleoplasm | 0.80 | 0.99 | 1 | 1 | 1 | 0.88 | 1 | 1
|
| 319 | 6118 | electron transport | 0.81 | 0.99 | 1 | 1 | 1 | 0.89 | 1 | 1
|
| 320 | 3824 | catalytic activity | 0.81 | 0.99 | 1 | 1 | 1 | 0.89 | 1 | 1
|
| 321 | 6950 | response to stress | 0.82 | 0.99 | 1 | 1 | 1 | 0.89 | 1 | 1
|
| 322 | 6996 | organelle organization and biogenesis | 0.82 | 0.99 | 1 | 1 | 1 | 0.90 | 1 | 1
|
| 323 | 6082 | organic acid metabolism | 0.83 | 0.99 | 1 | 1 | 1 | 0.90 | 1 | 1
|
| 324 | 19752 | carboxylic acid metabolism | 0.83 | 0.99 | 1 | 1 | 1 | 0.90 | 1 | 1
|
| 325 | 46907 | intracellular transport | 0.83 | 0.99 | 1 | 1 | 1 | 0.90 | 1 | 1
|
| 326 | 6355 | regulation of transcription, DNA-dependent | 0.83 | 0.99 | 1 | 1 | 1 | 0.90 | 1 | 1
|
| 327 | 45449 | regulation of transcription | 0.84 | 0.99 | 1 | 1 | 1 | 0.90 | 1 | 1
|
| 328 | 7275 | development | 0.85 | 0.99 | 1 | 1 | 1 | 0.90 | 1 | 1
|
| 329 | 8565 | protein transporter activity | 0.85 | 0.99 | 1 | 1 | 1 | 0.90 | 1 | 1
|
| 330 | 6351 | transcription, DNA-dependent | 0.85 | 0.99 | 1 | 1 | 1 | 0.90 | 1 | 1
|
| 331 | 8369 | obsolete molecular function | 0.86 | 0.99 | 1 | 1 | 1 | 0.92 | 1 | 1
|
| 332 | 5829 | cytosol | 0.87 | 0.99 | 1 | 1 | 1 | 0.92 | 1 | 1
|
| 333 | 6350 | transcription | 0.88 | 0.99 | 1 | 1 | 1 | 0.92 | 1 | 1
|
| 334 | 7028 | cytoplasm organization and biogenesis | 0.92 | 0.99 | 1 | 1 | 1 | 0.96 | 1 | 1
|
| 335 | 19538 | protein metabolism | 0.93 | 0.99 | 1 | 1 | 1 | 0.97 | 1 | 1
|
| 336 | 5524 | ATP binding | 0.94 | 0.99 | 1 | 1 | 1 | 0.98 | 1 | 1
|
| 337 | 30554 | adenyl nucleotide binding | 0.94 | 0.99 | 1 | 1 | 1 | 0.98 | 1 | 1
|
| 338 | 3677 | DNA binding | 0.94 | 0.99 | 1 | 1 | 1 | 0.98 | 1 | 1
|
| 339 | 16787 | hydrolase activity | 0.95 | 0.99 | 1 | 1 | 1 | 0.98 | 1 | 1
|
| 340 | 16817 | hydrolase activity, acting on acid anhydrides | 0.95 | 0.99 | 1 | 1 | 1 | 0.98 | 1 | 1
|
| 341 | 5623 | cell | 0.96 | 0.99 | 1 | 1 | 1 | 0.99 | 1 | 1
|
| 342 | 17076 | purine nucleotide binding | 0.96 | 0.99 | 1 | 1 | 1 | 0.99 | 1 | 1
|
| 343 | 166 | nucleotide binding | 0.96 | 0.99 | 1 | 1 | 1 | 0.99 | 1 | 1
|
| 344 | 8152 | metabolism | 0.97 | 0.99 | 1 | 1 | 1 | 0.99 | 1 | 1
|
| 345 | 16043 | cell organization and biogenesis | 0.97 | 0.99 | 1 | 1 | 1 | 0.99 | 1 | 1
|
| 346 | 5575 | cellular_component | 0.98 | 0.99 | 1 | 1 | 1 | 0.99 | 1 | 1
|
| 347 | 6139 | nucleobase, nucleoside, nucleotide and nucleic acid metabolism | 0.98 | 0.99 | 1 | 1 | 1 | 0.99 | 1 | 1
|
| 348 | 5622 | intracellular | 0.98 | 0.99 | 1 | 1 | 1 | 0.99 | 1 | 1
|
| 349 | 5634 | nucleus | 0.99 | 0.99 | 1 | 1 | 1 | 0.99 | 1 | 1
|
| 350 | 3676 | nucleic acid binding | 0.99 | 0.99 | 1 | 1 | 1 | 1 | 1 | 1
|
| 351 | 3673 | Gene_Ontology | 1 | 0.99 | 1 | 1 | 1 | 1 | 1 | 1
|